R. Garrick

发表

Contrast-Induced Nephropathy After Percutaneous Coronary Interventions in Relation to Chronic Kidney Disease and Hemodynamic Variables

R. Garrick, 2007 .

Kidney Function and Cognitive Impairment in US Adults: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study

R. Garrick, 2009 .

Regional Variation in Health Care Intensity and Treatment Practices for End-stage Renal Disease in Older Adults

R. Garrick, 2011 .

Noninvasive interrogation of microvasculature for signs of endothelial dysfunction in patients with chronic renal failure.

R. Garrick, M. Goligorsky, J. Stewart, 2004, American journal of physiology. Heart and circulatory physiology.

Associations among perceived and objective disease knowledge and satisfaction with physician communication in patients with chronic kidney disease

R. Garrick, 2012 .

Recurrent lactic acidosis and hypoglycemia with inadvertent metformin use: a case of look-alike pills

R. Garrick, Tess Jacob, M. Goldberg, 2017, Endocrinology, diabetes & metabolism case reports.

Fructose-induced hypertension: essential role of chloride and fructose absorbing transporters PAT1 and Glut5

R. Garrick, 2009 .

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

R. Garrick, 2010 .

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

R. Garrick, 2011 .

Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the Renin–Angiotensin System on Proteinuria in Renal Disease

R. Garrick, 2009 .

Independent and Additive Impact of Blood Pressure Control and Angiotensin II Receptor Blockade on Renal Outcomes in the Irbesartan Diabetic Nephropathy Trial: Clinical Implications and Limitations

R. Garrick, 2006 .

Serum Uric Acid in Normal and Hypertensive Australian Subjects:From a Continuing Epidemiological Survey on Hypertension Commenced in 1955.

R. Garrick, G. Bauer, C. Ewan, 1972 .

A Randomized, Controlled Trial of Early versus Late Initiation of Dialysis

R. Garrick, 2011 .

Cardiovascular Assessment of Diabetic End-Stage Renal Disease Patients Before Renal Transplantation

R. Garrick, 2011 .

Renal artery stent placement for the management of ischemic nephropathy.

R. Garrick, B. Dolmatch, P. Shah, 1998, Journal of vascular and interventional radiology : JVIR.

Renal artery stent placement for the management of ischemic nephropathy.

R. Garrick, B. Dolmatch, P. Shah, 1998, Journal of vascular and interventional radiology : JVIR.

Prevalence of CKD and Comorbid Illness in Elderly Patients in the United States: Results From the Kidney Early Evaluation Program (KEEP)

R. Garrick, 2010 .

Prevalence of Chronic Kidney Disease in the United States

R. Garrick, 2008 .

Progression Risk, Urinary Protein Excretion, and Treatment Effects of Angiotensin-Converting Enzyme Inhibitors in Nondiabetic Kidney Disease

R. Garrick, 2008 .

Baseline Predictors of Renal Disease Progression in the African American Study of Hypertension and Kidney Disease

R. Garrick, 2008 .

Relative Incidence of ESRD Versus Cardiovascular Mortality in Proteinuric Type 2 Diabetes and Nephropathy: Results From the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) Database

R. Garrick, 2012 .

Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study

R. Garrick, 2009 .

Body Mass Index and Risk for End-Stage Renal Disease

R. Garrick, 2007 .

Functional Status of Elderly Adults before and after Initiation of Dialysis

R. Garrick, 2010 .

Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes

R. Garrick, 2011 .

Effects of Dietary Sodium and Hydrochlorothiazide on the Antiproteinuric Efficacy of Losartan

R. Garrick, 2009 .

Renal Outcomes in High-Risk Hypertensive Patients Treated With an Angiotensin-Converting Enzyme Inhibitor or a Calcium Channel Blocker vs a Diuretic: A Report From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Rahman M, for the ALLHAT Collaborative Research

R. Garrick, 2006 .

Combination Therapy With an Angiotensin Receptor Blocker and an ACE Inhibitor in Proteinuric Renal Disease: A Systematic Review of the Efficacy and Safety Data

R. Garrick, 2007 .

Mitigating Contrast-Induced Acute Kidney Injury Associated With Cardiac Catheterization

R. Garrick, Maureen Brogan, M. Nunag, 2009, Cardiology in review.

Impact of Blood Pressure Control and Angiotensin-Converting Enzyme Inhibitor Therapy on New-Onset Microalbuminuria in Type 2 Diabetes: A Post Hoc Analysis of the BENEDICT Trial

R. Garrick, 2007 .

Impact of weight change on albuminuria in the general population

R. Garrick, 2008 .

Association of Single Measurements of Dipstick Proteinuria, Estimated Glomerular Filtration Rate, and Hematocrit with 25-Year Incidence of End-Stage Renal Disease in the Multiple Risk Factor Intervention Trial

R. Garrick, 2007 .

Kidney Function Can Improve in Patients with Hypertensive CKD

R. Garrick, 2012 .

Vasopressin Directly Regulates Cyst Growth in Polycystic Kidney Disease

R. Garrick, 2009 .

Sirolimus Therapy to Halt the Progression of ADPKD

R. Garrick, 2011 .

In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria

R. Garrick, 2010 .

Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes

R. Garrick, 2010 .

Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus

R. Garrick, 2011 .

Nephrogenic Systemic Fibrosis: Suspected Causative Role of Gadodiamide Used for Contrast-Enhanced Magnetic Resonance Imaging

R. Garrick, 2007 .

25-Hydroxyvitamin D Levels, Race, and the Progression of Kidney Disease

R. Garrick, 2010 .

Increase in Creatinine and Cardiovascular Risk in Patients with Systolic Dysfunction after Myocardial InfarctionJose P, for the SAVE Investigators (Harvard Med School; Univ of Melbourne, Australia; North Bristol NHS Trust, England; et al) J Am Soc Nephrol 17:2886–2891, 2006§

R. Garrick, 2007 .

Cystatin C Concentration as a Risk Factor for Heart Failure in Older AdultsSarnak MJ, for the Cardiovascular Health Study (Tufts-New England Med Ctr, Boston; et al) Ann Intern Med 142:497–505, 2005§

R. Garrick, 2006 .

Albuminuria, impaired kidney function and cardiovascular outcomes or mortality in the elderly

R. Garrick, 2010 .

Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes

R. Garrick, 2011 .

Association between estimated glomerular filtration rate at initiation of dialysis and mortality

R. Garrick, 2011 .

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis

M. Woodward, B. Astor, A. Levey, 2010, The Lancet.

Relation Between Serum Phosphate Level and Cardiovascular Event Rate in People With Coronary Disease

R. Garrick, 2007 .

Association of Kidney Function and Albuminuria With Cardiovascular Mortality in Older vs Younger Individuals: The HUNT II Study

R. Garrick, 2008 .

Macroalbuminuria Is a Better Risk Marker than Low Estimated GFR to Identify Individuals at Risk for Accelerated GFR Loss in Population Screening

R. Garrick, 2007 .

Prevalence of nephrogenic systemic fibrosis in renal insufficiency patients: Results of the FINEST study

R. Garrick, 2010 .

Effect of Pioglitazone on Cardiovascular Outcome in Diabetes and Chronic Kidney Disease

R. Garrick, 2009 .

Albuminuria and Estimated Glomerular Filtration Rate as Predictors of Diabetic End-Stage Renal Disease and Death

R. Garrick, 2012 .

Ketohexokinase-Dependent Metabolism of Fructose Induces Proinflam-matory Mediators in Proximal Tubular Cells

R. Garrick, 2010 .

Enzymatic formation and regulatory function of lipoxins and leukotriene B4 in rat kidney mesangial cells.

R. Garrick, P. Wong, 1991, Advances in experimental medicine and biology.

Transformation of leukotriene A4 to lipoxins by rat kidney mesangial cell.

R. Garrick, P. Wong, S. Y. Shen, 1989, Biochemical and biophysical research communications.

Supramaximal Dose of Candesartan in Proteinuric Renal Disease

R. Garrick, 2010 .

Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy

R. Garrick, 2009 .

Interference with TGF-β signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria

R. Garrick, 2008 .

Klotho Deficiency Causes Vascular Calcification in Chronic Kidney Disease

R. Garrick, 2011 .

Bicarbonate Supplementation Slows Progression of CKD and Improves Nutritional Status

R. Garrick, 2010 .

Effect of Intensive Lipid Lowering with Atorvastatin on Renal Function in Patients with Coronary Heart Disease: The Treating to New Targets (TNT) Study

R. Garrick, 2008 .

Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathy

R. Garrick, 2012 .

Comparison of Urinary Albumin and Urinary Total Protein as Predictors of Patient Outcomes in CKD

R. Garrick, 2011 .

Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study

R. Garrick, 2012 .

Homocysteine-Lowering and Cardiovascular Disease Outcomes in Kidney Transplant Recipients: Primary Results From the Folic Acid for Vascular Outcome Reduction in Transplantation Trial

R. Garrick, 2011 .

Predialysis Nephrology Care of Older Patients Approaching End-stage Renal Disease

R. Garrick, 2011 .

Biomarkers Predict Progression of Acute Kidney Injury after Cardiac Surgery

R. Garrick, 2012 .

Low Socioeconomic Status Associates with Higher Serum Phosphate Irrespective of Race

R. Garrick, 2011 .

Tolvaptan, a Selective Oral Vasopressin V2-Receptor Antagonist, for HyponatremiaSchrier RW, for the SALT Investigators (Univ of Colorado, Denver; et al) N Engl J Med 355:2099–2112, 2006§

R. Garrick, W. Frishman, 2007 .

Sodium Bicarbonate is Associated with an Increased Incidence of Contrast Nephropathy: A Retrospective Cohort Study of 7977 Patients at Mayo Clinic

R. Garrick, 2008 .

Renal Insufficiency and Mortality in Patients with Known or Suspected Coronary Artery Disease

R. Garrick, 2009 .

Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

R. Garrick, 2009 .

Albuminuria and Decline in Cognitive Function: The ONTARGET/TRANSCEND Studies

R. Garrick, 2011 .

Preeclampsia and the Risk of End-Stage Renal Disease

R. Garrick, 2009 .

Effect of B-Vitamin Therapy on Progression of Diabetic Nephropathy: A Randomized Controlled Trial

R. Garrick, 2010 .

Dilemmas in the Management of Atrial Fibrillation in Chronic Kidney Disease

R. Garrick, 2009 .

Pandemic Preparedness: COVID-19 Lessons Learned in New York's Hospitals

R. Garrick, Patrick J. McNulty, R. Panzer, 2022, The Joint Commission Journal on Quality and Patient Safety.

Renal Function and Risk of Hip and Vertebral Fractures in Older Women

R. Garrick, 2008 .

Frequency of and Risk Factors for Preventable Medication-Related Hospital Admissions in the Netherlands

R. Garrick, R. Garrick, 2009 .

Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy

R. Garrick, 2010 .

Amelioration of metabolic acidosis in patients with low GFR reduced kidney endothelin production and kidney injury, and better preserved GFR

R. Garrick, 2010 .

Acute-on-chronic kidney injury at hospital discharge is associated with long-term dialysis and mortality

R. Garrick, 2012 .

Epidemiology and Outcomes of Acute Renal Failure in Hospitalized Patients: A National Survey

R. Garrick, 2007 .

Metaanalysis: Low-Dose Dopamine Increases Urine Output but Does Not Prevent Renal Dysfunction or DeathFriedrich JO, Adhikari N, Herridge MS, et al (St Michaeľs Hosp, Toronto; Sunnybrook and Women's College, Toronto; Toronto Gen Hosp; et al) Ann Intern Med 142:510–524, 2005§

R. Garrick, 2006 .

High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database

R. Garrick, 2008 .

Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid

R. Garrick, 2012 .

Cardiovascular Outcomes in High-Risk Hypertensive Patients Stratified by Baseline Glomerular Filtration RateRahman M, for the ALLHAT Collaborative Research Group (Case Western Reserve Univ, Cleveland, Ohio; et al) Ann Intern Med 144:172–180, 2006§

R. Garrick, 2007 .

Chronic Kidney Disease Increases Risk for Venous Thromboembolism

R. Garrick, 2009 .

Endothelial Nitric Oxide Synthase Deficiency Produces Accelerated Nephropathy in Diabetic Mice

R. Garrick, 2007 .

Identifying High Risk Groups and Quantifying Absolute Risk of Cancer After Kidney Transplantation: A Cohort Study of 15 183 Recipients

R. Garrick, 2008 .

Beta-blockers for coronary heart disease in chronic kidney disease

R. Garrick, 2009 .

Contraindicated Medication Use in Dialysis Patients Undergoing Percutaneous Coronary Intervention

R. Garrick, 2010 .

AKI in the ICU: definition, epidemiology, risk stratification, and outcomes

R. Garrick, 2012 .

Physician Utilization, Risk-Factor Control, and CKD Progression Among Participants in the Kidney Early Evaluation Program (KEEP)

R. Garrick, 2012 .

Chronic Renal Dysfunction as an Independent Risk Factor for the Development of Cardiovascular Disease

R. Garrick, W. Frishman, J. McClung, 2005, Cardiology in review.

Differential diagnosis and pathophysiologic effects of hypercalcemia.

S. Goldfarb, R. Garrick, S. Goldfarb, 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Statins for Improving Renal Outcomes: A Meta-AnalysisSandhu S, Wiebe N, Fried LF, et al (Univ of Alberta, Edmonton, Canada; Univ of Pittsburgh, Pa) J Am Soc Nephrol 17:2006–2016, 2006§

R. Garrick, 2007 .

The severity of acute kidney injury predicts progression to chronic kidney disease

R. Garrick, R. Garrick, 2011 .

Comparative Mortality Risk of Anemia Management Practices in Incident Hemodialysis Patients

R. Garrick, 2010 .

Estimating GFR Using Serum Cystatin C Alone and in Combination With Serum Creatinine: A Pooled Analysis of 3,418 Individuals With CKD

R. Garrick, R. Garrick, 2008 .

Timing of Onset of CKD-Related Metabolic Complications

R. Garrick, 2010 .

Clinical Features and Outcomes of Anti–Glomerular Basement Membrane Disease in Older Patients

R. Garrick, 2011 .

Patient and facility safety in hemodialysis: opportunities and strategies to develop a culture of safety.

A. Kliger, R. Garrick, Alan Kliger, 2012, Clinical journal of the American Society of Nephrology : CJASN.

Highly Active Antiretroviral Therapy and the Kidney: An Update on Antiretroviral Medications for Nephrologists

R. Garrick, 2007 .

Adverse Safety Events in Chronic Kidney Disease: The Frequency of “Multiple Hits”

R. Garrick, R. Garrick, 2010 .

Novel Markers of Kidney Function as Predictors of ESRD, Cardiovascular Disease, and Mortality in the General Population

R. Garrick, 2012 .

Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate.

M. Woodward, A. Levey, M. Tonelli, 2012, JAMA.

Warfarin in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease

R. Garrick, 2012 .

Predictors of Hyperkalemia and Death in Patients With Cardiac and Renal Disease

R. Garrick, 2012 .

The Characteristics and Prognostic Importance of NT-ProBNP Concentrations in Critically Ill Patients

R. Garrick, 2008 .

Acute Kidney Injury in the Elderly Surgical Patient

R. Garrick, S. Chugh, T. Brevik, 2021 .

Relationship of Uric Acid With Progression of Kidney Disease

R. Garrick, 2008 .

Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease

R. Garrick, 2012 .

A Predictive Model for Progression of Chronic Kidney Disease to Kidney Failure

R. Garrick, R. Garrick, 2012 .

A Risk Score for Chronic Kidney Disease in the General Population

R. Garrick, 2012 .

A Simple Algorithm to Predict Incident Kidney Disease

R. Garrick, 2009 .

Prevalence of valve calcium and association of valve calcium with coronary artery disease, atherosclerotic vascular disease, and all-cause mortality in 137 patients undergoing hemodialysis for chronic renal failure.

W. Aronow, R. Garrick, M. Weiss, 2005, The American journal of cardiology.

Early acute kidney injury and sepsis: a multicentre evaluation

R. Garrick, 2008 .

Acute Kidney Injury Increases Risk of ESRD among Elderly

R. Garrick, 2009 .

Dialysis Facility Safety: Processes and Opportunities

R. Garrick, R. V. Morey, 2015, Seminars in dialysis.

Targeting Zero Infections in Hemodialysis.

A. Kliger, R. Garrick, 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Renoprotection of Optimal Antiproteinuric Doses (ROAD) Study: A Randomized Controlled Study of Benazepril and Losartan in Chronic Renal Insufficiency

R. Garrick, 2008 .

Aldosterone Antagonism in Chronic Kidney Disease

R. Garrick, 2007 .

Acute Phosphate Nephropathy Following Oral Sodium Phosphate Bowel Purgative: An Underrecognized Cause of Chronic Renal FailureMarkowitz GS, Stokes MB, Radhakrishnan J, et al (Columbia College of Physicians & Surgeons, New York) J Am Soc Nephrol 16:3389–3396, 2005§

R. Garrick, 2006 .

Incidence of thromboembolic stroke and of major bleeding in patients with atrial fibrillation and chronic kidney disease treated with and without warfarin

W. Aronow, R. Garrick, Sreedhar Adapa, 2009, International journal of nephrology and renovascular disease.

Does stage III chronic kidney disease always progress to end-stage renal disease? A ten-year follow-up study

R. Garrick, 2012 .

Cystatin C Identifies Chronic Kidney Disease Patients at Higher Risk for Complications

R. Garrick, R. Garrick, 2011 .

Intensive Diabetes Therapy and Glomerular Filtration Rate in Type 1 Diabetes

R. Garrick, 2012 .

Central Obesity, Incident Microalbuminuria, and Change in Creatinine Clearance in the Epidemiology of Diabetes Interventions and Complication Study

R. Garrick, 2008 .

A wearable haemodialysis device for patients with end-stage renal failure: a pilot study

R. Garrick, R. Garrick, 2008 .

All-cause mortality in hemodialysis patients with heart valve calcification

R. Garrick, 2012 .

Risk Factors for Hemodialysis and Mortality in Patients With Contrast-Induced Nephropathy

W. Aronow, R. Garrick, S. Chugh, 2011, American journal of therapeutics.

Bartter's syndrome: a unifying hypothesis.

S. Goldfarb, R. Garrick, D. Jorkasky, 1985, American journal of nephrology.

Amelioration of systemic hypertension by converting enzyme inhibition in the renal ablation model.

R. Garrick, L. Meggs, A. Goodman, 1988, American journal of hypertension.

Evidence-Based Practices to Reduce COVID-19 Transmission in Dialysis Facilities.

A. Kliger, R. Garrick, 2021, American Society of Nephrology. Clinical Journal.

Weekend Hospital Admission, Acute Kidney Injury, and Mortality

R. Garrick, 2011 .

Hepatocyte Growth Factor and Its Receptor Met Are Induced in Cresentic Glomerulonephritis

R. Garrick, 2006 .

Effect of a Very Low-Protein Diet on Outcomes: Long-term Follow-up of the Modification of Diet in Renal Disease (MDRD) Study

R. Garrick, 2009 .

Living-Donor Kidney Transplantation: A Review of the Current Practices for the Live Donor

R. Garrick, 2007 .

Incidence of thromboembolic stroke and of major bleeding in patients with atrial fibrillation and chronic kidney disease treated with and without warfarin.

W. Aronow, R. Garrick, Sreedhar Adapa, 2009, International journal of nephrology and renovascular disease.

High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease

R. Garrick, 2012 .

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Cinacalcet HCl in Participants With CKD Not Receiving Dialysis

R. Garrick, 2010 .

Low Health Literacy Associates with Increased Mortality in ESRD

R. Garrick, 2011 .

The Role of the Hospital in the Healthcare System

R. Garrick, J. Sullivan, M. Doran, 2019, The Modern Hospital.

Circulating TNF Receptors 1 and 2 Predict Stage 3 CKD in Type 1 Diabetes

R. Garrick, 2012 .

Use of Over-the-Counter Medications and Natural Products in Patients With Moderate and Severe Chronic Renal Insufficiency

R. Garrick, 2008 .